A month has gone by since the last earnings report for Incyte (INCY). Shares have added about 2.6% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

In this article, we are going to take a look at where Incyte Corporation (NASDAQ:INCY) stands against other best immunology stocks to buy now. Immunology is a rapidly advancing field with ...

Incyte (INCY – Research Report) received a Hold rating and price target from William Blair analyst Matt Phipps today. The company’s shares closed yesterday at $61.92. Easily identify stocks ...

In its upcoming report, Incyte (INCY) is predicted by Wall Street analysts to post quarterly earnings of $1.58 per share, reflecting an increase of 49.1% compared to the same period last year.

Wells Fargo analyst Derek Archila maintained a Hold rating on Incyte (INCY – Research Report) yesterday and set a price target of $58.00. The company’s shares closed yesterday at $62.01.

Fintel reports that on March 18, 2025, William Blair downgraded their outlook for Incyte (BMV:INCY) from Outperform to Market Perform. There are 1,211 funds or institutions reporting positions in ...